Tom Martin

Associate Chief Hematology, Director- Blood and Marrow Transplant,

[Tom Martin @TomMartinMD]

@HiraSMian @YiLinMDPhD World Class Dinner and award ceremony for Herman Einsele and Noopur Raje,MD - congrats to both and thanks you Heather, Vincent and Lisa!! @IMFmyeloma @VincentRK

[Tom Martin @TomMartinMD]

@HiraSMian @YiLinMDPhD Lucky to work with Yi Lin and Hira Mian at IMWG on new ideas/proposals in this amazing immunotherapy Era - bispecifics and Cars are best in early lines!!! @HiraSMian @YiLinMDPhD @IMFmyeloma

[Hira Mian @HiraSMian]

Room full at our IMWG immunotherapy meeting, thank you everyone for the great discussions #IMWG2026 with @TomBmt133 @YiLinMDPhD

[Tom Martin @TomMartinMD]

Amazing Physician, Researcher and Colleague - so well deserved - ayes an inspiration to us all!!!!

[Joshua Richter, MD, FACP @JoshuaRichterMD]

@NoopurRajeMD is simply a world class myeloma doctor and a world class human being. One of the most influential doctors in this space and an inspiration to patients and colleagues alike. Such a well deserved award @IMFmyeloma #mmsm

[Tom Martin @TomMartinMD]

@HiraSMian @JanakiramMurali @SusanBal9 @DrRakeshPopat @chngwj @H_Einsele @DoctorAKrishnan @YiLinMDPhD Awesome work team - thanks Murali for leading!!

[Tom Martin @TomMartinMD]

@COMyCongress @SagarLonialMD @szusmani @Mohty_EBMT Congrats Saad - well-deserved!!

[Tom Martin @TomMartinMD]

Amazing newtons as usual - that you Mohammed and the COMy team!!

[COMy @COMyCongress]

👀 Spotted Tom Martin after a great session, rocking his COMy tie

@TomBmt133 @Mohty_EBMT

[Tom Martin @TomMartinMD]

Inaugural “Harvesting Myeloma” CME program in Napa Valley - Chaired by Ajai Chari with Peter V and Ajay N giving first two talks - packed house with Vaniam Group providing awesome setting/support mark your calendar for 2027

[Society of Hematologic Oncology (SOHO) @SocietyofHemOnc]

"Accelerating.. bispecific adoption...is the highest impact goal that the research community can currently undertake."

@MileHighMyeloma & @LNastoupilMD talk managing access to novel agents in the community setting.

https://t.co/vLggGpRW9Z

[Tom Martin @TomMartinMD]

@jorgecortesmd @uabmedicine @ONealCancerUAB @icmlf @ASH_hematology @BloodGlobalHema Awesome Jorge - wishing you and your program the best - the MM program is great!!!

[Tom Martin @TomMartinMD]

If you haven’t seen this … it’s worth a read for all CAR enthusiasts. Eyquem lab - in Nature published site specific integration of in vivo CAR into the TRAC locus: anti BCMA,CD19, B7H3 CARs - all effective in NSG mice models @Myeloma_Society #mmsm

[Tom Martin @TomMartinMD]

And higher expression in HR -MM - looking forward to clinical trial

[Daniel Auclair @AuclairDan]

Nice work by @apwiita at @Myeloma_Society 7th Immune Effector Workshop showing why CD27 N88A may be best anti-CD70 CAR binder and how this AA impacts dissociation from CD70 #mmsm

[Anaya Khan @Rohcsnes]

@szusmani @realrickpazdur @MSKCancerCenter @MSK_DeptOfMed @IMFmyeloma @theMMRF @JAMAOnc @Myeloma_Society @VincentRK @NoopurRajeMD @SagarLonialMD @NikhilMunshiMD @myelomaMD @TomBmt133 @DoctorAKrishnan Hey saad I just saw your profile I think you like travelling ?

[Tom Martin @TomMartinMD]

Sorry need to add

[Tom Martin @TomMartinMD]

Amazing times … with many immunotherapy trials destined to answer the questions; cart 5/6, triumph, Master2, radar, EMN30, Linker-MM4,Midas ELLEN, HD-10, inMMyCAR, to name a few - every conference will share new insights!!

[Tom Martin @TomMartinMD]

March is Myeloma Action Month - so just started training for the IMF Iceland Cycling Expedition in August I. The distance is SF - have plenty of training to do

[Tom Martin @TomMartinMD]

Yes, very important to quickly define optimal duration but this will be optimized in Real World efforts. At ASH more than 1300 Tec patients described in RW abstracts

[Vincent Rajkumar @VincentRK]

@rajshekharucms @JNJInnovation Agree and we will make sure we have guidelines on this quick. Yi and Tom are aware of the importance of this. @YiLinMDPhD @TomBmt133

[Tom Martin @TomMartinMD]

Late Breaking ASH: Congrats to Mavie V and Tec-3 investigators. Practice changing and results we will ALL remember as part of ASH2025!!!

[Tom Martin @TomMartinMD]

DR Chung showing increased sustained MRD (-) rates - in those receiving Dara- Len vs Lem maintenance in the Aurora trial !

[Tom Martin @TomMartinMD]

@SagarLonialMD Amazing man - an inspiration for all including patients, researchers and HCPs. He mentored so many of us! He accomplished so much but his vision from the start was for a CURE in myeloma!! He will be dearly missed - best wishes to family, IMF and all our MM family. @IMFmyeloma